CAS 1011531-27-3

Fórmula: C24H19F3N2O4S

InChI: InChI=1S/C24H19F3N2O4S/c1-14-21(34-23(28-14)16-2-6-17(7-3-16)24(25,26)27)13-32-18-8-4-15(5-9-18)19(12-22(30)31)20-10-11-33-29-20/h2-11,19H,12-13H2,1H3,(H,30,31)/t19-/m0/s1

Chave InChI: BMLGZNVPWRUVNM-IBGZPJMESA-N

SMILES: CC1=C(SC(=N1)C2=CC=C(C=C2)C(F)(F)F)COC3=CC=C(C=C3)[C@H](CC(=O)O)C4=NOC=C4

AM-4668

CAS: 1011531-27-3

AM-4668

Fórmula: C₂₄H₁₉F₃N₂O₄S

Pureza: 99.5%

Peso molecular: 488.48

Ref: 54-BUP20963

AM-4668

CAS: 1011531-27-3

Fórmula: C₂₄H₁₉F₃N₂O₄S

Peso molecular: 488.4789

Ref: IN-DA01DZC0

AM 4668

Produto Controlado

CAS: 1011531-27-3

Fórmula: C₂₄H₁₉F₃N₂O₄S

Cor e Forma: Neat

Peso molecular: 488.479

Ref: TR-A634673

AM-4668

CAS: 1011531-27-3

AM-4668, a GPR40 (FFA1) agonist with oral availability, was optimized to reduce central nervous system (CNS) permeability, and reduced blood glucose level.

Fórmula: C₂₄H₁₉F₃N₂O₄S

Pureza: 99.32% - 99.92%

Cor e Forma: Solid

Peso molecular: 488.48

Ref: TM-T14202

AM 4668

CAS: 1011531-27-3

AM 4668 is a biochemical compound, which is derived from synthetic origins with complex organic synthesis processes. Its primary mode of action involves targeted enzymatic inhibition, effectively interacting with specific enzyme active sites to modulate biochemical pathways.

Fórmula: C₂₄H₁₉F₃O₄S

Pureza: Min. 95%

Peso molecular: 488.48 g/mol

Ref: 3D-LQB53127